Editorial: Alternative Therapeutics against MDR Bacteria - "Fighting the Epidemic of Antibiotic Resistance".
作者信息
Martins Marta, McCusker Matthew P
机构信息
Department of Microbiology, Moyne Institute of Preventive Medicine, School of Genetics and Microbiology, Trinity College Dublin, The University of Dublin Dublin, Ireland.
School of Food Science and Environmental Health, College of Sciences and Health, Dublin Institute of Technology Dublin, Ireland.
出版信息
Front Microbiol. 2016 Oct 7;7:1559. doi: 10.3389/fmicb.2016.01559. eCollection 2016.
Abstract
摘要
相似文献
1
Editorial: Alternative Therapeutics against MDR Bacteria - "Fighting the Epidemic of Antibiotic Resistance".社论：针对多重耐药菌的替代疗法——“对抗抗生素耐药性流行”
Front Microbiol. 2016 Oct 7;7:1559. doi: 10.3389/fmicb.2016.01559. eCollection 2016.
2
Editorial: Alternative Therapeutics Against Antimicrobial-Resistant Pathogens.社论：针对抗微生物病原体的替代疗法
Front Microbiol. 2019 Sep 19;10:2173. doi: 10.3389/fmicb.2019.02173. eCollection 2019.
3
Repurposing screens identify rifamycins as potential broad-spectrum therapy for multidrug-resistant Acinetobacter baumannii and select agent microorganisms.重新利用筛选方法发现利福霉素类药物可能成为治疗多重耐药鲍曼不动杆菌和选择剂微生物的广谱疗法。
Future Microbiol. 2012 Aug;7(8):1011-20. doi: 10.2217/fmb.12.75.
4
Antibiotic adjuvants: an alternative approach to overcome multi-drug resistant Gram-negative bacteria.抗生素佐剂：克服多重耐药革兰氏阴性菌的另一种方法。
Crit Rev Microbiol. 2019 May;45(3):301-314. doi: 10.1080/1040841X.2019.1599813. Epub 2019 Apr 15.
5
Repurposed Antimicrobial Combination Therapy: Tobramycin-Ciprofloxacin Hybrid Augments Activity of the Anticancer Drug Mitomycin C Against Multidrug-Resistant Gram-Negative Bacteria.抗菌联合疗法的重新利用：妥布霉素-环丙沙星杂合体增强抗癌药物丝裂霉素C对多重耐药革兰氏阴性菌的活性。
Front Microbiol. 2019 Jul 10;10:1556. doi: 10.3389/fmicb.2019.01556. eCollection 2019.
6
Loci Encoding Compounds Potentially Active against Drug-Resistant Pathogens amidst a Decreasing Pool of Novel Antibiotics.在新型抗生素数量不断减少的情况下，基因座编码化合物具有对抗耐药病原体的潜力。
Appl Environ Microbiol. 2019 Nov 14;85(23). doi: 10.1128/AEM.01438-19. Print 2019 Dec 1.
7
Strategies to Combat Multidrug-Resistant and Persistent Infectious Diseases.对抗多重耐药和持续性传染病的策略
Antibiotics (Basel). 2020 Feb 6;9(2):65. doi: 10.3390/antibiotics9020065.
8
From Nano to Micro: using nanotechnology to combat microorganisms and their multidrug resistance.从纳米到微观：利用纳米技术对抗微生物及其多药耐药性。
FEMS Microbiol Rev. 2017 May 1;41(3):302-322. doi: 10.1093/femsre/fux003.
9
Antibacterial and antibiotic-resistance modifying activity of the extracts and compounds from Nauclea pobeguinii against Gram-negative multi-drug resistant phenotypes.诺氏乌檀提取物及化合物对革兰氏阴性多药耐药表型的抗菌及抗生素耐药性修饰活性
BMC Complement Altern Med. 2016 Jul 7;16:193. doi: 10.1186/s12906-016-1173-2.
10
The impact of multiple drug resistance (MDR) proteins on chemotherapy and drug discovery.
Prog Drug Res. 2002;58:99-131. doi: 10.1007/978-3-0348-8183-8_3.
引用本文的文献
1
Armed Phages: A New Weapon in the Battle Against Antimicrobial Resistance.武装噬菌体：对抗抗生素耐药性的新武器
Viruses. 2025 Jun 27;17(7):911. doi: 10.3390/v17070911.
2
Antibacterial Efficacy of Polysaccharide Capped Silver Nanoparticles Is Not Compromised by AcrAB-TolC Efflux Pump.多糖包覆银纳米颗粒的抗菌功效不受AcrAB-TolC外排泵的影响。
Front Microbiol. 2018 May 4;9:823. doi: 10.3389/fmicb.2018.00823. eCollection 2018.
3
Activated Mesenchymal Stem Cells Interact with Antibiotics and Host Innate Immune Responses to Control Chronic Bacterial Infections.激活的间充质干细胞与抗生素和宿主固有免疫反应相互作用，以控制慢性细菌感染。
Sci Rep. 2017 Aug 29;7(1):9575. doi: 10.1038/s41598-017-08311-4.
本文引用的文献
1
Dissimilar Fitness Associated with Resistance to Fluoroquinolones Influences Clonal Dynamics of Various Multiresistant Bacteria.与氟喹诺酮耐药性相关的不同适应性影响多种多重耐药菌的克隆动态。
Front Microbiol. 2016 Jul 7;7:1017. doi: 10.3389/fmicb.2016.01017. eCollection 2016.
2
Intensity and Mechanisms of Fluoroquinolone Resistance within the H30 and H30Rx Subclones of Escherichia coli Sequence Type 131 Compared with Other Fluoroquinolone-Resistant E. coli.与其他耐氟喹诺酮类大肠杆菌相比，131型大肠杆菌H30和H30Rx亚克隆内氟喹诺酮耐药性的强度及机制
Antimicrob Agents Chemother. 2015 Aug;59(8):4471-80. doi: 10.1128/AAC.00673-15. Epub 2015 May 18.
3
Fitness cost associated with resistance to fluoroquinolones is diverse across clones of Klebsiella pneumoniae and may select for CTX-M-15 type extended-spectrum β-lactamase.与氟喹诺酮类药物耐药性相关的适应性成本在肺炎克雷伯菌的不同克隆之间存在差异，并且可能选择 CTX-M-15 型超广谱β-内酰胺酶。
Eur J Clin Microbiol Infect Dis. 2014 May;33(5):837-43. doi: 10.1007/s10096-013-2022-6. Epub 2013 Dec 4.
4
Identification and evolution of drug efflux pump in clinical Enterobacter aerogenes strains isolated in 1995 and 2003.1995年和2003年分离的临床产气肠杆菌菌株中药物外排泵的鉴定与进化
PLoS One. 2008 Sep 12;3(9):e3203. doi: 10.1371/journal.pone.0003203.
Zotero 插件